This research evaluates the effects of various gene therapy viral vectors on RPE cells to determine efficacy for therapeutic ...
A patient has died after receiving the high dose of Neurogene’s Rett syndro | A patient has died after receiving the high ...
Delivering very large genes to cells can pose a serious challenge, so scientists developed a new method. | Genetics And ...
SRN-101 is a recombinant adeno-associated viral (AAV) vector expressing an engineered cytokine. Last year, Siren ...
OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical developmentOxford, UK – 20 ...
In a bid to streamline viral vector manufacturing, Thermo Fisher is charting another round of layoffs this year—and ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
Following this update, the company's stock price dropped more than 30 percent from market close Friday to $23.79 per share Monday morning.
The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus ...
Gene therapy for some diseases, including Duchenne muscular dystrophy (DMD), can be tricky because the needed gene is often ...
SRD-001/2/3 employ an adeno-associated virus (AAV)-based vector system, delivered directly to cardiac ventricular muscle cells via Sardocor’s proprietary intracoronary infusion system. Furthermore, ...